Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $201.45 | Total: $1,007.25 |
| 1 | 10 | $170.64 | Total: $1,706.40 |
| 1 | 25 | $144.57 | Total: $3,614.25 |
| 1 | 50 | $123.24 | Total: $6,162.00 |
| 1 | 100 | $106.65 | Total: $10,665.00 |
Overview
Minzasolmin(DLX-313) is an alpha-synuclein misfolding inhibitor for the study of Parkinson's disease.
Chemical Properties
| Molecular Formula | C23H31N5OS |
| Molecular Weight | 425.59 |
| CAS Numbers | 1802518-92-8 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C([C@H](NC(=O)C=1SC(=NC1)N2CCN(C)CC2)CCCC)C=3C=4C(NC3)=CC=CC4 |
Storage and Handling
0C Short Term, -20C Long Term
References
Price DL,et al. In vivo effects of the alpha-synuclein misfolding inhibitor minzasolmin supports clinical development in Parkinson's disease. NPJ Parkinsons Dis. 2023 Jul 17;9[1] 114.